Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Repligen Corp
Today
Create an eToro account to buy RGEN stock on a secure, user-friendly, multi-asset trading platform.
Buy Repligen Corp
Buy Repligen Corp
Repligen Corp RGEN
Buy RGEN
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
180
Based on analysts who covered RGEN

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Repligen Corp News

Stocks-RGEN-Repligen Corp

Repligen Corp RGEN

$147.965.52(3.87%)(1D)
• Nasdaq • in USD

RGEN Stock Price Chart

‎1.65‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Repligen Corp share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Repligen Corp share price today is $147.96, reflecting a ‎3.87‎% change over the last 24 hours and ‎-2.11‎% over the past week. The current market capitalization of RGEN is 7.98B with an average volume in the last three months of 618795.64. The stock has a P/E ratio of -312.16 and a dividend yield of 0%. With the stock’s beta sitting at 1.47
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$7.98B
Day’s Range
i
Shows the high and low prices of the day.
135.51 - 165.1
52W Range
i
Shows the high and low prices of the last year.
110.28 - 210.58
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
618795.64
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-312.16
Revenue
i
The total income generated by this company’s goods and services last year.
$634.44M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$142.44
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-0.46
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.47
What Is Repligen Corp?
Repligen Corp is an American bioprocessing company engaged in the development, production, and commercialisation of high-value, innovative products used in the process of manufacturing biologic drugs. The firm supplies a range of customers worldwide, including life sciences companies, global biopharmaceutical firms, and contract manufacturers. The firm was founded in 1981 and is based in Boston, Massachusetts. In addition to operating manufacturing sites in Massachusetts, Repligen Corp also owns sites in California, Sweden, and Germany.

The company has contributed to various important medical advances including products for cell culture intensification, tangential flow depth filtration, pre-packed columns, single-use cassettes, and integrated tangential flow filtration (TFF) systems. Repligen Corp is a leading manufacturer of Protein A affinity ligands, which are a critical component of Protein A resins used in the manufacture of monoclonal antibody therapeutics.

The firm’s products are marketed to customers across the globe through a direct commercial organisation operating in the United States, Europe, and Asia. Repligen Corp also works with strategic partners and distributors in select markets. The firm trades on the NASDAQ, where it is publicly listed under the stock ticker RGEN.

Use your eToro watchlist to monitor the RGEN price chart and receive real-time news updates and information on Repligen Corp.
Buy RGEN

How can I buy Repligen Corp stocks?

To purchase Repligen Corp:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Repligen Corp (RGEN) page and place an order to buy Repligen Corp.
Buy RGEN
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Repligen Corp
Invest in Repligen Corp
Today
Create an eToro account to buy RGEN stock on a secure, user-friendly, multi-asset trading platform.
Buy RGEN

FAQ

The current price of RGEN is $147.96.
The average price target for Repligen Corp is $147.96. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Repligen Corp based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Repligen Corp is $7.98B
Daily Movers
Explore the biggest stocks movers on the market.
Buy RGEN
Scroll to top